Colossal Biosciences wants to create new animals that resemble extinct creatures like the woolly mammoth, thanks to advancements in genetic engineering and synthetic biology. In this conversation from the WSJ’s Future of Everything Festival in May 2024, Colossal Biosciences co-founder and CEO Ben Lamm discusses how the de-extinction of species could help address the loss of biodiversity and benefit ecosystems. He tells Future of Everything editorial director Stefanie Ilgenfritz about his plans for monetizing the technology, and how it could be used for human health.
What do you think about the show? Let us know on Apple Podcasts or Spotify, or email us: FOEPodcast@wsj.com 
Sign up for the WSJ's free The Future of Everything newsletter.
Further reading: 
Return of the Woolly Mammoth? 
Doctors Can Now Edit the Genes Inside Your Body 
How Ancient Hunters Felled Massive Mammoths and Hungry Predators 
Learn more about your ad choices. Visit megaphone.fm/adchoices

Could Making a New Woolly Mammoth Help Human Health?

Colossal Biosciences wants to create new animals that resemble extinct creatures like the woolly mammoth, thanks to advancements in genetic engineering and synthetic biology. In this conversation from the WSJ’s Future of Everything Festival in May 2024, Colossal Biosciences co-founder and CEO Ben Lamm discusses how the de-extinction of species could help address the loss [&hellip;]